Published in Transfusion on October 01, 2001
Transfusion-related acute lung injury: incidence and risk factors. Blood (2011) 3.12
Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission. Blood (2004) 2.89
The Epidemiology of Transfusion-related Acute Lung Injury Varies According to the Applied Definition of Lung Injury Onset Time. Ann Am Thorac Soc (2015) 1.39
Transfusion-related acute lung injury (TRALI): current concepts and misconceptions. Blood Rev (2009) 1.26
Transfusion-related acute lung injury (TRALI): a clinical review with emphasis on the critically ill. Br J Haematol (2009) 1.23
Experimental prestorage filtration removes antibodies and decreases lipids in RBC supernatants mitigating TRALI in vivo. Blood (2014) 1.11
The role of neutrophils in the pathogenesis of transfusion-related acute lung injury. Transfus Med Rev (2009) 1.06
Transfusion-Related Acute Lung Injury: Incidence, Pathogenesis and the Role of Multicomponent Apheresis in Its Prevention. Transfus Med Hemother (2008) 1.05
Transfusion reactions: newer concepts on the pathophysiology, incidence, treatment, and prevention of transfusion-related acute lung injury. Crit Care Clin (2012) 0.97
TRALI--definition, mechanisms, incidence and clinical relevance. Best Pract Res Clin Anaesthesiol (2007) 0.92
Transfusion-related acute lung injury. CMAJ (2007) 0.91
Intravenous immunoglobulin prevents murine antibody-mediated acute lung injury at the level of neutrophil reactive oxygen species (ROS) production. PLoS One (2012) 0.85
Transfusion-related acute lung injury in the Canadian paediatric population. Paediatr Child Health (2012) 0.83
The management of hospitalized patients with cirrhosis: the Mount Sinai experience and a guide for hospitalists. Dig Dis Sci (2011) 0.82
Rapid-Onset Acute Respiratory Distress Syndrome (ARDS) in a Patient Undergoing Metastatic Liver Resection: A Case Report and Review of the Literature. Anesthesiol Res Pract (2010) 0.81
TRALI associated with HLA class II antibodies. Transfusion (2003) 0.80
Reducing blood transfusion. BMJ 's cover and headline exaggerated importance of study's findings. BMJ (2002) 0.79
Experimental models of transfusion-related acute lung injury. Transfus Med Rev (2011) 0.78
Transfusion-related acute lung injury (TRALI)--an important, severe transfusion-related complication. Langenbecks Arch Surg (2006) 0.77
TRALI associated with HLA class II antibodies. Transfusion (2002) 0.76
Pulmonary complications of transfused blood components. Crit Care Nurs Clin North Am (2012) 0.75
Therapeutic options for transfusion related acute lung injury; the potential of the G2A receptor. Curr Pharm Des (2012) 0.75
The association between red blood cell and platelet transfusion and subsequently developing idiopathic pneumonia syndrome after hematopoietic stem cell transplantation. Transfusion (2013) 0.75
Transfusion-Related Acute Lung Injury (TRALI): Report of 2 Cases and a Review of The Literature. Ochsner J (2008) 0.75
Computer-based interview for screening blood donors for risk of HIV transmission. JAMA (1992) 4.01
Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion (1985) 3.35
Transfusion-associated hepatitis not due to viral hepatitis type A or B. N Engl J Med (1975) 3.31
Australia antigen: large-scale purification from human serum and biochemical studies of its proteins. J Virol (1971) 3.28
Microtiter solid-phase radioimmunoassay for hepatitis B antigen. Appl Microbiol (1973) 2.96
Transmissible agent in non-A, non-B hepatitis. Lancet (1978) 2.78
The association of biologically active lipids with the development of transfusion-related acute lung injury: a retrospective study. Transfusion (1997) 2.67
Type B hepatitis: the infectivity of blood positive for e antigen and DNA polymerase after accidental needlestick exposure. N Engl J Med (1976) 2.67
The natural history of transfusion-associated infection with human immunodeficiency virus. Factors influencing the rate of progression to disease. N Engl J Med (1989) 2.58
A complement-fixation test for measuring Australia antigen and antibody. J Infect Dis (1969) 2.58
Biophysical properties of Australia antigen. J Virol (1969) 2.45
Clinical and serological analysis of transfusion-associated hepatitis. Lancet (1975) 2.41
Hypotensive reactions: a previously uncharacterized complication of platelet transfusion? Transfusion (1996) 2.37
Type B hepatitis after needle-stick exposure: prevention with hepatitis B immune globulin. Final report of the Veterans Administration Cooperative Study. Ann Intern Med (1978) 2.29
A controlled trial of educational outreach to improve blood transfusion practice. JAMA (1993) 2.28
Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood. Ann Intern Med (1986) 2.27
Evaluation of assays for antibody to hepatitis E virus by a serum panel. Hepatitis E Virus Antibody Serum Panel Evaluation Group. Hepatology (1998) 2.06
Transfusion-associated graft-versus-host disease. Vox Sang (2008) 2.05
A comparison of the frequency of hepatitis-B antigen and antibody in hospital and nonhospital personnel. N Engl J Med (1973) 2.05
Radioimmunoassay for the detection of the core of the Dane particle and antibody to it. Intervirology (1974) 2.02
Seroepidemiology of viral infections among intravenous drug users in northern California. West J Med (1992) 2.01
Questionable efficacy of confidential unit exclusion. Transfusion (1990) 1.81
Improved serodiagnosis of hepatitis C virus infection with synthetic peptide antigen from capsid protein. Proc Natl Acad Sci U S A (1991) 1.81
Prevalence of and risk factors for antibody to hepatitis E virus seroreactivity among blood donors in Northern California. J Infect Dis (1997) 1.79
Biophysical characterization of the adr subtype of hepatitis B antigen and preparation of anti-r sera in rabbits. J Immunol (1975) 1.75
Transfusion-related acute lung injury associated with passive transfer of antileukocyte antibodies. Am Rev Respir Dis (1983) 1.68
Posttransfusion hepatitis after exclusion of commercial and hepatitis-B antigen-positive donors. Ann Intern Med (1972) 1.64
Improved survival with plasma exchange in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Am J Med (1999) 1.63
Preparation and characterization of complement-fixing hepatitis-associated antigen and antiserum. J Infect Dis (1970) 1.62
Macroglobulinemia: an analysis for forty patients. Blood (1972) 1.61
Survival of donor leukocyte subpopulations in immunocompetent transfusion recipients: frequent long-term microchimerism in severe trauma patients. Blood (1999) 1.59
Subtyping of hepatitis-associated antigen (HB-Ag); simplified technique with counterelectrophoresis. J Immunol (1972) 1.54
Transfusion to blood group A and O patients of group B RBCs that have been enzymatically converted to group O. Transfusion (2000) 1.49
A case-controlled multicenter study of vasovagal reactions in blood donors: influence of sex, age, donation status, weight, blood pressure, and pulse. Transfusion (1999) 1.48
Lyme disease--another transfusion risk? Transfusion (1989) 1.45
Counterelectrophoresis for detection of hepatitis--associated antigen: methodology and comparison with gel diffusion and complement fixation. J Lab Clin Med (1971) 1.44
Donor attitudes about exporting and importing blood. Transfusion (1997) 1.43
Cocoa inhibits platelet activation and function. Am J Clin Nutr (2000) 1.42
Replacement therapy of alpha 1-antitrypsin deficiency. Reversal of protease-antiprotease imbalance within the alveolar structures of PiZ subjects. J Clin Invest (1981) 1.41
Needlestick injuries in blood collection staff. A retrospective analysis. Transfusion (1989) 1.41
HIV transmissions from a window-period platelet donation. Am J Clin Pathol (2001) 1.38
Autologous blood transfusion in the 1990s. Where is it heading? Am J Clin Pathol (1992) 1.38
Infection and America's blood supply: a 1998 status report. Am J Clin Pathol (1998) 1.38
Non-A, non-B hepatitis and antibody to hepatitis C virus. JAMA (1990) 1.37
Circannual variation in lymphocyte subsets, revisited. Transfusion (1994) 1.32
Platelet activation and function after trauma. J Trauma (2001) 1.30
Simian retrovirus D serogroup 1 has a broad cellular tropism for lymphoid and nonlymphoid cells. J Virol (1988) 1.29
Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test. Transfusion (2005) 1.26
False positive tests for hepatitis-associated antigen in blood donors caused by antibodies to ruminant serum proteins. J Immunol (1972) 1.26
T or B cell origin of some non-Hodgkin's lymphomas. Lancet (1974) 1.24
Donor transaminase and recipient hepatitis. Impact on blood transfusion services. JAMA (1981) 1.24
Relation of hepatitis-B-antigen subtypes in symptom-free carriers to geographical origin and liver abnormalities. Lancet (1973) 1.23
Transmission of hepatitis B to chimpanzees by hepatitis B surface antigen-positive saliva and semen. Infect Immun (1977) 1.22
The Duffy blood group phenotype in American blacks infected with Plasmodium vivax in Vietnam. Am J Trop Med Hyg (1978) 1.21
The development of HBsAg-positive hepatitis despite the previous existence of antibody to HBsAg. J Immunol (1976) 1.16
Irradiation of blood products. Indications and guidelines. Transfusion (1985) 1.16
Health-care workers positive for hepatitis B surface antigen. Are their contacts at risk? N Engl J Med (1975) 1.15
Bigger is better: maternal and neonatal predictors of hematopoietic potential of umbilical cord blood units. Bone Marrow Transplant (2001) 1.14
The Ausria test: critical evaluation of sensitivity and specificity. Blood (1973) 1.13
Growth of bacteria in inoculated platelets: implications for bacteria detection and the extension of platelet storage. Transfusion (2000) 1.12
Anti-HIV seroprevalence in California blood and plasma donors. West J Med (1988) 1.12
Differentiation of hepatitis B virus genotypes D and E by ELISA using monoclonal antibodies to epitopes on the preS2-region product. J Virol Methods (2000) 1.12
Hemostatic defects in dysproteinemias. Blood (1970) 1.10
The binding of murine IgM to Staphylococcal A protein. Scand J Immunol (1978) 1.10
Hepatitis B antigen: regional variation in incidence and subtype ratio in the American Red Cross donor population. Am J Epidemiol (1973) 1.08
Antibody to hepatitis-associated antigen. Frequency and pattern of response as detected by radioimmunoprecipitation. JAMA (1972) 1.07
The prevalence of hepatitis C virus antibodies among hemodialysis patients. Ann Intern Med (1990) 1.07
Detection of acute hepatitis C virus infection by ELISA using a synthetic peptide comprising a structural epitope. Proc Natl Acad Sci U S A (1992) 1.05
Gamma-globulin in the prophylaxis of posttransfusion hepatitis. JAMA (1966) 1.05
Pathogenesis of simian AIDS in rhesus macaques inoculated with the SRV-1 strain of type D retrovirus. Am J Vet Res (1986) 1.04
Seroepidemiological studies of transfusion-associated hepatitis. J Infect Dis (1971) 1.03
Delayed hemolytic transfusion reaction with acute renal failure. JAMA (1968) 1.02
Visual assessment of hemolysis in red blood cell units and segments can be deceptive. Transfusion (2004) 1.01
Studies on the pathogenesis of an immune defect in multiple myeloma. J Clin Invest (1977) 1.01
Perceptions and preferences of autologous blood donors. Transfusion (1998) 1.01
Computer interview for screening blood donors for risk of HIV transmission. MD Comput (1994) 1.00
Hepatitis B, hepatitis C and HIV transfusion-transmitted infections in the 21st century. Vox Sang (2011) 1.00
Transfusion-related acute lung injury. Br J Haematol (1999) 0.99
Anaphylactic reactions to IgA: a difficult transfusion problem. Am J Clin Pathol (1970) 0.99
Waldenström's macroglobulinemia: correlation between expanded plasma volume and increased serum viscosity. Blood (1970) 0.99
Peripheral-blood mononuclear cell responses to recombinant hepatitis C virus antigens in patients with chronic hepatitis C. Hepatology (1993) 0.99
On the rare ayr phenotype of hepatitis B Antigen. Intervirology (1973) 0.99
Screening of blood donors for idiopathic CD4+ T-lymphocytopenia. Transfusion (1994) 0.99
Cutaneous extramedullary plasmacytomas. Arch Dermatol (1969) 0.97
Alloimmunization in two multitransfused patient populations. Transfusion (1981) 0.97
The clinical significance of anti-H in an individual with the Oh (Bombay) phenotype. Transfusion (1979) 0.96
Significance of antibody to hepatitis B core antigen in blood donors as determined by their serologic response to hepatitis B vaccine. Transfusion (1993) 0.96
The emerging pattern of post-transfusion hepatitis. Am J Med Sci (1977) 0.95
Non-A, non-B post-transfusion hepatitis. Lancet (1977) 0.94
Crystalline IgG protein in multiple myeloma: identification effects on coagulation and on lipoprotein metabolism. J Lab Clin Med (1972) 0.94
Multiple myeloma: an immunologic profile. I. Peripheral blood studies. J Immunol (1977) 0.94
Thrombocytosis, coronary thrombosis and acute myocardial infarction. Am J Med (1979) 0.93
Red blood cell transfusion practices in patients undergoing orthopedic surgery: a multi-institutional analysis. Orthopedics (1998) 0.93
Hepatitis C virus in blood samples from volunteer donors. J Clin Microbiol (1993) 0.93
Decreased phorbol myristate acetate-induced release of tumor necrosis factor-alpha and interleukin-1 beta from peripheral blood monocytes of patients chronically infected with hepatitis C virus. J Infect Dis (1996) 0.93
Experiences of the first 493 unrelated marrow donors in the National Marrow Donor Program. Blood (1993) 0.93
Why a new standard to prevent Creutzfeldt-Jakob disease. Transfusion (1988) 0.91
Infection with HIV-2 in a resident of the United States. N Engl J Med (1990) 0.90